Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Deficit

v3.20.1
Condensed Statements of Stockholders' Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2018 $ 928 $ 2,046,056 $ (2,548,735) $ (501,751)
Balance, shares at Mar. 31, 2018 9,275,000      
Stock-based compensation expense 643,503 643,503
Stock-based compensation expense, shares      
Issuance of common stock in connection with notes payable $ 60 239,940   240,000
Issuance of common stock in connection with notes payable, shares 600,000      
Beneficial conversion feature in connection with notes payable   138,708   138,708
Net loss     (2,444,920) (2,444,920)
Balance at Dec. 31, 2018 $ 988 3,068,207 (4,993,655) (1,924,460)
Balance, shares at Dec. 31, 2018 9,875,000      
Balance at Sep. 30, 2018 $ 988 2,862,590 (4,095,670) (1,232,092)
Balance, shares at Sep. 30, 2018 9,875,000      
Stock-based compensation expense 205,617 205,617
Stock-based compensation expense, shares      
Net loss (897,985) (897,985)
Balance at Dec. 31, 2018 $ 988 3,068,207 (4,993,655) (1,924,460)
Balance, shares at Dec. 31, 2018 9,875,000      
Balance at Mar. 31, 2019 $ 988 3,448,857 (6,844,488) (3,394,643)
Balance, shares at Mar. 31, 2019 9,875,000      
Issuance of common stock in connection with a consulting agreement $ 32 239,968   240,000
Issuance of common stock in connection with a consulting agreement, shares 320,000      
Stock-based compensation expense $ 600 3,713,356   3,713,956
Stock-based compensation expense, shares 6,000,000      
Issuance of common stock and warrants in connection with cancellation of consulting agreement $ 10 264,510   264,520
Issuance of common stock and warrants in connection with cancellation of consulting agreement, shares 100,000      
Issuance of common stock in connection with notes payable $ 42 320,958   321,000
Issuance of common stock in connection with notes payable, shares 421,000      
Beneficial conversion feature in connection with notes payable   27,918   27,918
Net loss     (7,301,685) (7,301,685)
Balance at Dec. 31, 2019 $ 1,672 8,015,567 (14,146,173) (6,128,934)
Balance, shares at Dec. 31, 2019 16,716,000      
Balance at Sep. 30, 2019 $ 1,640 6,663,488 (11,870,918) (5,205,790)
Balance, shares at Sep. 30, 2019 16,396,000      
Stock-based compensation expense 1,112,111 1,112,111
Stock-based compensation expense, shares      
Issuance of common stock and warrants in connection with cancellation of consulting agreement $ 32 239,968   240,000
Issuance of common stock and warrants in connection with cancellation of consulting agreement, shares 320,000      
Net loss (2,275,255) (2,275,255)
Balance at Dec. 31, 2019 $ 1,672 $ 8,015,567 $ (14,146,173) $ (6,128,934)
Balance, shares at Dec. 31, 2019 16,716,000